251. University of California Davis Details Findings in Personalized Medicine (Precision Nutrition and Cardiovascular Disease Risk Reduction: the Promise of High-density Lipoproteins).
- Subjects
HIGH density lipoproteins ,INDIVIDUALIZED medicine ,DIET in disease ,CARDIOVASCULAR diseases risk factors ,CARDIOVASCULAR diseases - Abstract
Elucidating the nuances of HDL structure and function at an individual level may unlock personalized dietary and lifestyle strategies to optimize HDL-mediated atheroprotection and reduce CVD risk. According to the news reporters, the research concluded: "Precision nutrition strategies that account for personalized metabolic, genetic, and lifestyle data hold promise for optimizing HDL therapies and function to mitigate CVD risk more potently. Keywords: Davis; State:California; United States; North and Central America; Cardiology; Cardiovascular; Cardiovascular Diseases and Conditions; Cardiovascular Research; Diet and Nutrition; Drugs and Therapies; HDL Lipoproteins; Health and Medicine; Lipid Research; Lipids; Lipoproteins; Peptides and Proteins; Personalized Medicine; Personalized Therapy; Proteins; Risk and Prevention EN Davis State:California United States North and Central America Cardiology Cardiovascular Cardiovascular Diseases and Conditions Cardiovascular Research Diet and Nutrition Drugs and Therapies HDL Lipoproteins Health and Medicine Lipid Research Lipids Lipoproteins Peptides and Proteins Personalized Medicine Personalized Therapy Proteins Risk and Prevention 1485 1485 1 11/06/23 20231110 NES 231110 2023 NOV 6 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- New research on Drugs and Therapies - Personalized Medicine is the subject of a report. [Extracted from the article]
- Published
- 2023